Forward osmosis utilizing a controllable osmotic agent

Details for Australian Patent Application No. 2005299387 (hide)

International Classifications

Event Publications

7 June 2007 Amendment Made

The nature of the amendment is: Amend the priority details to read 60/622,148 25 Oct 2004 US 2005299837 Janssen Pharmaceutica, N.V. The nature of the amendment is: Add priority details 60/670,172 11 Apr 2005 US 2005302618 Novartis AG The nature of the amendment is: Amend the invention title to read Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent for enhanced absorption

7 June 2007 PCT application entered the National Phase

PCT publication WO2006/047577 Priority application(s): WO2006/047577

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.